In addition, the DAGs inferred from both the breast cancer and melanoma datasets suggest that a decrease in CD8+ T cells is driven indirectly through CCN4 expression via modulating cancer-associated fibroblasts or the activity of NK cells. The gene discussed is CD8A; the disease is cancer.